Toggle light / dark theme

Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD

TruDiagnostic Discount Link (Epigenetic Testing)
CONQUERAGING!
https://bit.ly/3Rken0n.

Bristle Discount Link (Oral Microbiome Quantification):
ConquerAging15
https://www.bmq30trk.com/4FL3LK/GTSC3/

Quantify Discount Link (At-Home Blood Testing)

The United States Air Force unveiled the B-21 Raider, a high-tech stealth bomber that can carry nuclear and conventional weapons and is designed to be able to fly without a crew on board. The fleet is estimated to cost $203 billion to develop, buy and operate over 30 years, according to Bloomberg, with the US planning to acquire at least 100 of the aircraft.

Much of the features of the warplane are shrouded in mystery, with reports suggesting that it has the potential for an uncrewed flight. A US Air Force spokeswoman said the aircraft was “provisioned for the possibility, but there has been no decision to fly without a crew”.

The first flight by a B-21 is expected to take place next year.

Researchers at Stanford and Singapore’s Nanyang Technological University (NTU) have developed a technique for controlling neurons from a distance, without invasive implants.

By injecting a molecule called TRPV1 — which helps us sense the heat in capsaicin chili peppers — into the brains of mice, they could control specific brain cells from up to one meter (about three feet) using infrared light beams.

The ability to impact neurons, without invasive surgical methods or tethers sticking out of skulls, could help researchers study the brain during more normal behavior, like mice socializing together.

Beijing, China — Dec 4, 2022 (CCTV — No access Chinese mainland) 1. Various of ground control team working 2. Screen showing Shenzhou-14 separating from space station combination.

In Space — Dec 4, 2022 (China Manned Space Agency — No access Chinese mainland) 3. Shenzhou-14 spacecraft.

Beijing, China — Dec 4, 2022 (CCTV — No access Chinese mainland) 4. Various of screen showing Shenzhou-14 separating from space station combination 5. Various of screen showing space station combination 6. Screen showing Shenzhou-14 separating from space station combination.

The world’s first artificial liver has been grown from stem cells by British scientists. The resulting “mini-liver” is the size of a small coin; the same technique will be further developed to create a full-size liver.

The mini-liver is useful as it is; within two years it can be used to test new drugs, reducing the number of animal experiments as well as providing results based on a human (rather than animal) liver.

Human pancreas-on-a-chip (PoC) technology is quickly advancing as a platform for complex in vitro modeling of islet physiology. This review summarizes the current progress and evaluates the possibility of using this technology for clinical islet transplantation.

PoC microfluidic platforms have mainly shown proof of principle for long-term culturing of islets to study islet function in a standardized format. Advancement in microfluidic design by using imaging-compatible biomaterials and biosensor technology might provide a novel future tool for predicting islet transplantation outcome. Progress in combining islets with other tissue types gives a possibility to study diabetic interventions in a minimal equivalent in vitro environment.

Although the field of PoC is still in its infancy, considerable progress in the development of functional systems has brought the technology on the verge of a general applicable tool that may be used to study islet quality and to replace animal testing in the development of diabetes interventions.